Sogo Clinical Holdings <2399> is April third quarter financial results for the period July now, and made a presentation on a new business partnership.
(5.6% year-on-year) 4.9 billion 11 million yen in sales, 3Q earnings, operating income (up 21.7% year-on-year) 800 000 000 2 million yen. Full-year plan has been affirmed the prior forecast.
In addition, comprehensive HD announced its entry into the regenerative medicine business using the pulp tissue and cell at the same time. The business alliance with PREMEDICO companies conduct research of the business, to expand long-term storage of tissues and cells, development and sales of regenerative medicine, the development and manufacturing of regenerative medicine equipment. Alliance period of business alliance will be a mechanism to one year from the 6th June, contract per year is updated.
Closing price of the 6th comprehensive HD is 148,300 yen of 17,900 yen depreciation compared with the day before.
(5.6% year-on-year) 4.9 billion 11 million yen in sales, 3Q earnings, operating income (up 21.7% year-on-year) 800 000 000 2 million yen. Full-year plan has been affirmed the prior forecast.
In addition, comprehensive HD announced its entry into the regenerative medicine business using the pulp tissue and cell at the same time. The business alliance with PREMEDICO companies conduct research of the business, to expand long-term storage of tissues and cells, development and sales of regenerative medicine, the development and manufacturing of regenerative medicine equipment. Alliance period of business alliance will be a mechanism to one year from the 6th June, contract per year is updated.
Closing price of the 6th comprehensive HD is 148,300 yen of 17,900 yen depreciation compared with the day before.